Clinically Relevant Efficacy of Insulin Therapy in Patients with Type 2 Diabetes

被引：3

作者：

Boussageon, Remy ^{[1
]}

Gamble, John-Michael ^{[2
]}

Gueyffier, Francois ^{[4
,5
,6
]}

Cornu, Catherine ^{[3
,4
,5
,6
]}

机构：

[1] Fac Poitiers, Dept Gen Practice, Poitiers, France

[2] Mem Univ Newfoundland, Sch Pharm, St John, NF, Canada

[3] INSERM, CIC201, F-69008 Lyon, France

[4] Lyon Univ, Lyon, France

[5] CHU Lyon, Louis Pradel Hosp, Lyon, France

[6] CNRS, UMR5558, Lyon, France

来源：

THERAPIE | 2013年 / 68卷 / 06期

关键词：

insulin; randomized controlled trial; type 2 diabetes mellitus; CARDIOVASCULAR-DISEASE; HEART-FAILURE; MORTALITY; RISK; COMPLICATIONS; METAANALYSIS; ASSOCIATION; EVENTS; DEATH;

D O I：

10.2515/therapie/2013063

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：415 / 417

页数：3

共 19 条

[1]

[Anonymous], 1982, Diabetes, V31 Suppl 5, P1

[2]

[Anonymous], 2005, NAT DIAB FACT SHEET

[3] Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials [J].

Boussageon, Remy ;

Supper, Irene ;

Bejan-Angoulvant, Theodora ;

Kellou, Nadir ;

Cucherat, Michel ;

Boissel, Jean-Pierre ;

Kassai, Behrouz ;

Moreau, Alain ;

Gueyffier, Francois ;

Cornu, Catherine .

PLOS MEDICINE, 2012, 9 (04)

[4] Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials [J].

Boussageon, Remy ;

Bejan-Angoulvant, Theodora ;

Saadatian-Elahi, Mitra ;

Lafont, Sandrine ;

Bergeonneau, Claire ;

Kassai, Behrouz ;

Erpeldinger, Sylvie ;

Wright, James M. ;

Gueyffier, Francois ;

Cornu, Catherine .

BMJ-BRITISH MEDICAL JOURNAL, 2011, 343

[5] Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin [J].

Bowker, SL ;

Majumdar, SR ;

Veugelers, P ;

Johnson, JA .

DIABETES CARE, 2006, 29 (02) :254-258

[6] Emergency Hospitalizations for Adverse Drug Events in Older Americans [J].

Budnitz, Daniel S. ;

Lovegrove, Maribeth C. ;

Shehab, Nadine ;

Richards, Chesley L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (21) :2002-2012

[7] The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern [J].

Currie, C. J. ;

Johnson, J. A. .

DIABETES OBESITY & METABOLISM, 2012, 14 (01) :1-4

[8] A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association functional class I or II heart failure [J].

Dargie, Henry J. ;

Hildebrandt, Per R. ;

Riegger, Guenter A. J. ;

McMurray, John J. V. ;

McMorn, Stephen O. ;

Roberts, Jeremy N. ;

Zambanini, Andrew ;

Wilding, John P. H. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (16) :1696-1704

[9] Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review [J].

Eurich, Dean T. ;

McAlister, Finlay A. ;

Blackburn, David F. ;

Majumdar, Sumit R. ;

Tsuyuki, Ross T. ;

Varney, Janice ;

Johnson, Jeffrey A. .

BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7618) :497-501

[10] Insulin use and increased risk of mortality in type 2 diabetes: a cohort study [J].

Gamble, J. -M. ;

Simpson, S. H. ;

Eurich, D. T. ;

Majumdar, S. R. ;

Johnson, J. A. .

DIABETES OBESITY & METABOLISM, 2010, 12 (01) :47-53

← 1 2 →